Sort
8,912 grants matching “sars cov 2”
Long-Term Endothelial Effects of COVID-19 in Obesity
$663,087Jennifer E Ho · Beth Israel Deaconess Medical Center · R01 · FY2024 · HL
Enhancing Novel Research for Inflammation and Cognitive Health among Adolescents and Young Adults Living with Perinatally Acquired HIV and Adversity (ENRICH+)
$662,913Reuben N Robbins · Columbia University Health Sciences · R01 · FY2025 · HD
Immunologic basis of cardiac disease after severe COVID-19
$662,793Chetan N Shenoy · University Of Minnesota · R01 · FY2025 · HL
Inhalation Therapy Platform for Coronavirus Infection Treatment
$662,579Patrick S. Stayton · University Of Washington · R01 · FY2023 · AI
Engineering the Skin Immune System to Induce Systemic Immune Responses
$662,528Louis D Falo · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AR
Electrophysiological representations of odor in the human brain
$662,328Christina Maria Zelano · Northwestern University At Chicago · R01 · FY2025 · DC
Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with APOL1 High-Risk Genotypes
$662,080Girish Nitin Nadkarni · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19
$662,044Jie Sun · University Of Virginia · R01 · FY2024 · HL
Understanding the Risk of Bat Coronavirus Emergence
$661,980Peter Daszak · Ecohealth Alliance, Inc. · R01 · FY2019 · AI
COVID-19 vaccine development
$661,794George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Community Developed Technology-Based Messaging to Increase SARS-CoV-2 Vaccine Uptake Among People Who Inject Drugs
$661,600Ian David Aronson · New York University · R01 · FY2022 · DA
Site Specific Immunophenotyping Assays of COVID19 Patients to Align with NIAID National Study
$661,549Nitin S Baliga · Institute For Systems Biology · R01 · FY2020 · AI
Brain pathophysiology in SARS-CoV-2 disease
$661,469Kathryn L Sandberg · Georgetown University · R01 · FY2021 · NS
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients
$661,105Mario C. Deng · University Of California Los Angeles · R01 · FY2023 · AI
Multi-Dimensional Outcome Prediction Algorithm for Hospitalized COVID-19 Patients
$661,105Mario C. Deng · University Of California Los Angeles · R01 · FY2024 · AI
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
$661,066Priyamvada Acharya · Duke University · R01 · FY2025 · AI
COVID Transmission and Morbidity in Malawi (COVID-TMM)
$661,062Clarissa Valim · Boston University Medical Campus · R01 · FY2022 · AI
Role of Complement Activation in Severe COVID-19
$660,854Xuebin Qin · Tulane University Of Louisiana · R01 · FY2024 · HL
Inflammation, Macrophage Differentiation, and Cancer
$660,538Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Regulation of germinal center responses by SARS-CoV-2 messenger RNA vaccines
$660,497Michela Locci · University Of Pennsylvania · R01 · FY2022 · AI
COVID Supplement - IGF MAINTENANCE OF NIAID SPECIFIC PATHOGEN-FREE MACAQUE BREEDING COLONIES
$660,000Greg Westergaard · Alpha Genesis Inc · N01 · FY2021 · AI
Emergent Advocacy Coalitions and SARS-CoV-2 Vaccine Hesitancy: The influence of beliefs and narratives on individual decision-making
$660,000David M Abramson · New York University · · FY2021 · SBE
B-cell response and thrombotic complications in COVID-19
$659,871Renren Wen · Versiti Wisconsin, Inc. · R01 · FY2023 · HL
B-cell response and thrombotic complications in COVID-19
$659,871Renren Wen · Versiti Blood Health, Inc. · R01 · FY2025 · HL
B-cell response and thrombotic complications in COVID-19
$659,871Renren Wen · Versiti Wisconsin, Inc. · R01 · FY2022 · HL